Despite renewed enthusiasm for the use of willingness to pay (WTP) in
healthcare applications, there are still a lot of objections, resentme
nt and scepticism regarding the desirability and feasibility of this t
echnique. Objections can be classified into different categories: e.g.
theoretical, feasibility of measurement, misunderstanding of economic
concepts and emotional. In this commentary, I have tried to explain t
he nature of the 'emotional' objections to the use of WTP. I argue tha
t such objections are not helpful and distract attention from the prop
er scientific debates about the important topics of theoretical founda
tion for economic evaluations and feasibility of measurement of indivi
duals' WTP. I believe that some of the emotional objections to WTP ste
m from perceptions about the relationship between the WTP measure and
actual payment for health services. Hence, I discuss the use of the WT
P methodology in 2 distinct contexts - cost - benefit analysis (CBA) a
nd market research. Understanding the difference between these 2 most
common areas of use will help alleviate objections based on emotions,
allow us to use the technique where there seems to be no objections to
its use (i.e. market research) and concentrate on the scientific deba
te where objections exist (i.e. the case of CBA).